Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,250,388,797
+$520,676,945 QoQ
Shares Held
48,641,158
+2.1% QoQ
Ownership
1.97%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#8
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 48%
Shared 0%
None 52%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $63,698,443,803 across 20 Drug Manufacturers - General names. MRK ranks #4 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,226,398 | $19,462,430,163 | |
| 2 | JNJ |
Johnson & Johnson
|
44,808,254 | $11,379,952,259 | |
| 3 | ABBV |
AbbVie Inc.
|
38,901,001 | $9,789,047,884 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
48,641,158 | $6,250,388,797 | |
| 5 | AMGN |
Amgen Inc
|
13,653,692 | $4,944,274,940 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,004,354 | $3,032,710,073 | |
| 7 | PFE |
Pfizer Inc
|
96,345,452 | $2,319,998,477 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,009,025 | $1,671,500,010 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,250,388,797 | 48,641,158 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $5,729,711,852 | 47,632,487 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,731,018,162 | 44,946,021 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $3,742,147,871 | 44,586,535 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $3,498,926,930 | 44,200,694 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $3,869,953,202 | 43,114,452 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,395,394,367 | 44,183,699 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $5,041,135,297 | 44,391,822 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $5,226,509,281 | 42,217,361 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $5,476,697,558 | 41,505,855 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $4,374,953,514 | 40,129,825 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $3,973,333,931 | 38,594,793 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $4,519,551,318 | 39,167,617 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,153,978,497 | 39,044,821 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,643,266,478 | 41,850,081 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,259,578,695 | 37,849,265 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,462,224,778 | 37,975,483 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,091,631,804 | 25,492,161 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,255,127,626 | 29,424,943 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,963,217,814 | 26,137,902 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,044,534,100 | 26,289,496 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $1,731,242,668 | 22,457,410 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,846,173,302 | 22,569,366 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,604,905,476 | 19,347,857 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,445,621,716 | 18,694,182 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,379,695,271 | 17,932,101 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||